258 related articles for article (PubMed ID: 12959644)
21. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
Xu KT; Moloney M; Phillips S
Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
[TBL] [Abstract][Full Text] [Related]
22. [Consequences of ALLHAT: Thiazides rehabilitated--time to change prescription patterns].
Hernborg A; Håkansson J; Werkö L; Berglund G
Lakartidningen; 2003 Feb; 100(6):408-10. PubMed ID: 12607432
[No Abstract] [Full Text] [Related]
23. [Thiazides in the treatment of hypertension].
Meland E; Flottorp S
Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3088; author reply 3088-9. PubMed ID: 14618189
[No Abstract] [Full Text] [Related]
24. [Why not always diuretics?].
Omvik P; Lund-Johansen P
Tidsskr Nor Laegeforen; 2004 May; 124(10):1419-20. PubMed ID: 15195187
[TBL] [Abstract][Full Text] [Related]
25. [Cost-effective drug utilization--thiazides are still available].
Lund-Roland L
Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2637. PubMed ID: 11668768
[No Abstract] [Full Text] [Related]
26. [Are the newer antihypertensive agents better and more effective than diuretics?].
Landmark K
Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
[TBL] [Abstract][Full Text] [Related]
27. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
Jünger C; Rathmann W; Giani G
Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
[TBL] [Abstract][Full Text] [Related]
28. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].
Anlauf M; Hense HW
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069
[No Abstract] [Full Text] [Related]
29. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
[TBL] [Abstract][Full Text] [Related]
30. Containing the costs of managing hypertension.
Arnolda L
Med J Aust; 2001 Jun; 174(11):556-7. PubMed ID: 11453324
[No Abstract] [Full Text] [Related]
31. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
Siegel D; Lopez J
JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
[TBL] [Abstract][Full Text] [Related]
32. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
Balu S
Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
34. [Revival of antihypertensive therapy: use of thiazide diuretics].
Nagy V
Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317
[TBL] [Abstract][Full Text] [Related]
35. [A gigantic meta-analysis confirms: thiazides are best as the first choice medication in hypertension; new guidelines are necessary].
Lindblad U; Hernborg A; Melander A
Lakartidningen; 2003 Jun; 100(24):2155-6. PubMed ID: 12841113
[No Abstract] [Full Text] [Related]
36. Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.
Wright JM
CMAJ; 2000 Jul; 163(1):57-60. PubMed ID: 10920733
[TBL] [Abstract][Full Text] [Related]
37. Availability of thiazide diuretics in Chandigarh.
Malhotra S; Pandhi P
J Assoc Physicians India; 2000 Sep; 48(9):943. PubMed ID: 11198812
[No Abstract] [Full Text] [Related]
38. [Use of antihypertensive drugs in Spain, 1985-1995].
Prieto M; de Abajo FJ; Montero D; Martín-Serrano G; Madurga M; Palop R
Med Clin (Barc); 1998 Feb; 110(7):247-53. PubMed ID: 9562948
[TBL] [Abstract][Full Text] [Related]
39. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
de los Rios JC; Ortíz Feijoo J; Otero Cagide F
Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
[No Abstract] [Full Text] [Related]
40. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
Fischer MA; Avorn J
JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]